Send us Feedback

PetMed Express (PETS)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
PetMed Express Announces a 20% Increase to Its Quarterly Dividend
Benzinga  Jan 30  Comment 
PetMed Express, Inc. (Nasdaq: PETS) today announced that its Board of Directors declared a quarterly dividend of $0.15 per share on its common stock, compared to the $0.125 per share dividend that has been paid in prior quarters. The dividend will...
Benzinga's Volume Gainers
Benzinga  Jan 23  Comment 
A number of notable stocks are moving higher on Monday on very heavy volume despite a broader market which is marginally lower on the session. Among the names that traders may want to keep an eye on are PetMed Express (NASDAQ: PETS), BroadVision...
Bank of America Raises EPS on PetMed after 3Q Revenue Report
Benzinga  Jan 23  Comment 
Bank of America has published a research report on PetMed Express (NASDAQ: PETD) after the company reported 3Q revenues that outran company costs. In the report, Bank of America writes, "Revenue growth (+12%) was higher than our forecast (-2%),...
PetMed Express Up 19% After Earnings Beat
Benzinga  Jan 23  Comment 
Shares of PetMed Express are up more than 19% after the company beat on earnings this morning. PetMed Express, Inc. (Nasdaq: PETS) today announced its financial results for the quarter ended December 31, 2011. Net sales for the quarter ended...
Movers & Shakers: Monday’s biggest gaining and declining stocks
MarketWatch  Jan 23  Comment 
MarketWatch’s daily rundown of major gainers and decliners in the U.S. stock market.
PetMed Express Reports Q3 EPS $0.19 vs $0.16 Est; Revenues $50.50M vs $44.75M Est
Benzinga  Jan 23  Comment 
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
Indications: U.S. futures flat; RIM and PetMed shares active
MarketWatch  Jan 23  Comment 
U.S. stock futures are flattish ahead of the start of the trading week on Wall Street, as investors eye talks between Greece and its creditors. Research In Motion, PetMed Express and Columbia Laboratories come in for scrutiny.
PetMed Express d/b/a 1-800-PETMEDS to Announce Its Third Quarter Financial Results on January 23, 2012
Globe Newswire  Jan 17  Comment 
POMPANO BEACH, Fla., Jan. 17, 2012 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (Nasdaq:PETS) will announce its financial results for the quarter ended December 31, 2011 on Monday, January 23, 2012 at 8:00 A.M. Eastern Time, then at 8:30 A.M. Eastern
PetMed Express d/b/a 1-800-PetMeds Announces Its Quarterly Dividend
Globe Newswire  Oct 31  Comment 
POMPANO BEACH, Fla., Oct. 31, 2011 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (Nasdaq:PETS) today announced that its Board of Directors declared a quarterly dividend of $0.125 per share on its common stock. The dividend will be payable on November 25,
PetMed Express Q2 Earnings 2011 Track Lower
Morningpick  Oct 24  Comment 
PetMed Express PETS today announced its financial results for the quarter ended September 30, 2011. Net sales for the quarter ended September 30, 2011 were $58.2 million, compared to $61.2 million for the quarter ended September 30, 2010, a...




more ▼WIKI ANALYSIS
 
TOP CONTRIBUTORS
Director
Robert Plaza
www.zacks.com

PetMed Express and subsidiaries, doing business as 1-800-PetMeds, is a leading nationwide pet pharmacy. The company markets its health products for dogs, cats, and horses direct to the consumer through national television, online, and direct mail advertising campaigns in an effort to increase the recognition of its 1-800-PetMeds brand name, increase traffic to its website www.1800petmeds.com, acquire new customers, and maximize repeat customers. The company's fiscal year ends March 31 and is located in Pompano Beach, Florida.

PetMed Express offers a broad selection of products for dogs, cats, and horses. These products include brands of medication such as Frontline Plus , K9 Advantix , Advantage , Heartgard Plus , Sentinel , and Interceptor . The company offers two types of products: Non-Prescription Medications and Prescription medications. Non-prescription medications include flea and tick control, bone and joint care, vitamins, nutritional supplements, and hygiene products. Prescription medications include heartworm treatments, thyroid and arthritis meds, antibiotics, and other specialty meds.

Over the last three years, the company's sales by segment have been 70% for non-prescription products, 29% for prescription products, and 1% for shipping and handling fees.




References

Pet Meds Investor Relations Pet Meds News

Retrieved from "http://www.wikinvest.com/stock/PetMed_Express_(PETS)"
Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki